Key facts
- David Denton will become Nike's new Chief Financial Officer on August 17.
- Denton previously served as CFO and Executive Vice President at Pfizer.
- Matthew Friend is stepping down as CFO but will stay until September 4.
- Denton has over 30 years of experience in finance and operating leadership.
- Elliott Hill, Nike's CEO, stated Denton's experience will help execute company priorities.
Nike has appointed David Denton, formerly the Chief Financial Officer of Pfizer, as its new Executive Vice President and Chief Financial Officer. The transition is set to take effect on August 17, with Matthew Friend, the current CFO, stepping down on that date. Friend will continue with Nike until September 4 to facilitate an orderly handover.
Denton brings over three decades of experience in finance and operations from various global public companies, including previous roles as CFO at Lowe's Companies and CVS Health Corporation. Nike President and CEO Elliott Hill expressed confidence in Denton's ability to support the company's strategic priorities, emphasizing his experience with consumer brands and operational rigor.
Friend is scheduled to participate in Nike's fourth quarter fiscal 2026 earnings call on June 30 as planned. Nike stated that the company's fourth-quarter results are expected to be largely in line with previous guidance, with an anticipated benefit from tariff refunds not factored into earlier projections.